With the recent completion of the relocation of our headquarters and research operations to the Songdo Global R&PD Center, SK bioscience is laying the foundation for its next leap forward as a global biopharmaceutical leader. This center goes beyond a conventional research facility, integrating the full spectrum of vaccine development—from basic research to process development—into a single, connected ecosystem. As Korea’s most advanced vaccine-dedicated research center, it will serve as a global platform for innovation. From this powerful base, SK bioscience aims to formally usher in the SKBS 3.0 era, accelerating its advance into the global market.

Today, the global vaccine and biopharmaceutical industry is confronting profound change, driven by population aging, the rise of chronic diseases, and the growing permanence of emerging infectious diseases. In this period of rapid transformation, only companies that combine technological innovation, rapid development capabilities, and stable manufacturing capacity can demonstrate true leadership. Against this backdrop, SK bioscience remains firmly committed to continuous challenge and progress.

Over the past quarter century, SK bioscience has built an independent vaccine value chain, supplying vaccines essential to public health—including those for COVID-19, influenza, herpes zoster, varicella, and typhoid fever. Among our current pipeline, the 21-valent and next-generation pneumococcal vaccines are expected to serve as key drivers of the company’s sustainable growth.

Looking ahead, we will strengthen our in-house development capabilities through Songdo’s cutting-edge infrastructure, expand global partnerships built on trust, and further solidify our role as a global vaccine manufacturing hub connecting Andong L HOUSE and IDT Biologika in Germany.

We will continue to pursue a path where our public mission to serve humanity and our passion for technological innovation coexist in balance. By presenting new global standards for the vaccine and biopharmaceutical industry, SK bioscience will move forward with unwavering determination toward a healthier future for humanity.